In recent years, new ablation catheters have been developed to facilitate atrial fibrillation (AF) ablation procedures, including the multi-electrode pulmonary vein ablation catheter (PVAC), capable of using different proportions of unipolar and bipolar energy. The purpose of this study was to evaluate the acute efficacy, as well as safety, when using the two different energy settings for the PVAC catheter.
Methods and Results:Thirty-five patients with a mean age of 62 ± 7.7 years with paroxysmal (54%) or persistent AF were included in the study and randomized to 4:1 versus 2:1 bipolar/unipolar energy setting with the PVAC device. The mean number of applications with the PVAC catheter was 41 ± 10 and 51 ± 15 (p = 0.3) respectively with the 4:1 and the 2:1 setting. Touch-up with another RF ablation catheter was necessary in 3 and 7 patients respectively in the 4:1 and 2:1 group. The procedure time was 155 ± 35 and 174 ± 41minutes respectively and the total fluoroscopy time, including the time for touch-up with another catheter, was 42 ± 14 and 50 ± 17 minutes respectively with the 4:1 versus 2:1 setting. No complications were seen in any group.
Conclusion:There was no significant difference between the 4:1 and 2:1 bipolar-tounipolar energy setting with the PVAC regarding the number of applications needed to create (PVI), the number of patients in which (PVI) could be achieved without touch-up applications, the procedure time or the fluoroscopy time. studies that have compared the different settings for this purpose. The aim of this study was therefore to compare the efficacy and safety of PV isolation using a 4:1 versus a 2:1 unipolar/bipolar energy setting with the PVAC. Our hypothesis was that the 2:1 setting, delivering more unipolar energy, would result in deeper and more transmural lesions for pulmonary vein isolation leading to fewer applications and thus shorter procedure times.
Methods
PatientsThe patients included in this single-center study was a subset of patients in a larger randomized study comparing the PVAC and the CryoCath cryo-balloon (both Medtronic; Minneapolis, MN, USA) and were included between